# Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia

> **NCT02575235** · EARLY_PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Sarcopenia

## Interventions

- **DRUG:** Cetylpyridinium Chloride (CPC)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02575235
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-01
- **Primary completion:** 2016-07-01
- **Final completion:** 2016-07-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02575235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02575235, "Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02575235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*